Endocrinology

Top Story

HbA1c more sensitive than OGTT for identifying prediabetes

HbA1c more sensitive than OGTT for identifying prediabetes
August 25, 2016

HbA1c and oral glucose tolerance tests used to identify prediabetes yielded conflicting results in both Hispanic and non-Hispanic white populations in New Mexico, study data show.

“Diagnostic tests for prediabetes will often provide different answers depending upon which test is ordered,” Mark R. Burge, MD, professor of medicine, endocrinology and metabolism at the University of New Mexico Health Sciences Center in Albuquerque, told Endocrine Today. “HbA1c appears to provide a more sensitive test for prediabetes in a population heavily enriched in Hispanic individuals.”

In the Journals Plus

New European blood pressure targets for diabetes may put patients at risk

August 24, 2016
Recently raised systolic blood pressure targets for people with diabetes may put them at elevated risk for stroke and myocardial infarction, study data show. In…
In the Journals Plus

Eight additional cancer types associated with excess body fatness

August 24, 2016
The WHO’s International Agency for Research on Cancer working group identified an additional eight types of cancer associated with excess body fatness, including…
In the Journals Plus

Tight glycemic control benefits questionable for microvascular, macrovascular complications

August 24, 2016
Tight glycemic control confers no substantial benefit on the risk for microvascular or macrovascular complications, despite a consistent RR reduction for nonfatal…
Meeting News Coverage

Insulin glargine, detemir effective in treating inpatient hyperglycemia

August 24, 2016
NEW ORLEANS — Insulin detemir and insulin glargine were found to be equally effective in managing patients with diabetes, with no significant differences between…
More News Headlines »
CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
Video
Meeting News Coverage

VIDEO: Diabetes educators can help people with diabetes overcome barriers to exercise

August 16, 2016
More »
Featured
ADA 2016

ADA 2016

CME CNE CPE

The Emerging Biosimilar Therapeutic Landscape: Scientific Foundations and Clinical Implications

This activity is supported by an educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Recent processes have been established to facilitate the production, validation, and utilization of biosimilars…
More »
Current Issues
View the Current Issues
morganatic-roan